The groundbreaking rise of Viagra has long been a example of pharmaceutical success, however its legacy within the broader market now triggers questions about long-term gains. Copycat versions are diminishing exclusivity , causing concerns that supporting companies heavily reliant to Viagra's previous position could be a speculative strategy, espec